Department of Medicine
-
October 24, 2013
Study sheds new light on type 2 diabetes development
Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found. -
October 14, 2013
Magnesium impacts vitamin D status
Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. -
October 10, 2013
Talbot lands epidemiology award
Thomas Talbot, M.D., MPH, associate professor of Medicine and Chief Hospital Epidemiologist at Vanderbilt University Medical Center, received the 2013 Investigator Award from the Society for Healthcare Epidemiology of America (SHEA) at the organization’s Annual Scientific Meeting last week in San Francisco. -
October 10, 2013
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. -
October 3, 2013
Study finds cognitive deficits common after critical illness
Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. -
October 3, 2013
Framingham Heart Study’s landmark impact examined
While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. -
September 18, 2013
Fishing for new anti-cancer drugs
Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.